Heart failure with preserved ejection fraction in elderly patients with hypertension who do not have diabetes mellitus, coronary heart disease, or cardiac arrhythmia: focus on clinical portrait
- Authors: Barsukov A.V.1,2, Airapetyan A.V.1,3, Glebova S.A.1, Saraev G.B.4, Borisova E.V.1,3
-
Affiliations:
- KardioKlinika
- S.M. Kirov Military Medical Academy, Ministry of Defense of Russia
- I.I. Mechnikov North-West State Medical University, Ministry of Health of Russia
- Saint Petersburg Institute of Bioregulation and Gerontology
- Issue: Vol 36, No 9 (2025)
- Pages: 79-82
- Section: From Practice
- URL: https://journal-vniispk.ru/0236-3054/article/view/315158
- DOI: https://doi.org/10.29296/25877305-2025-09-15
- ID: 315158
Cite item
Abstract
Heart failure with preserved ejection fraction (HFpEF) accounts for up to half of all cases of HF. Left ventricular diastolic dysfunction is the main link in the pathogenesis of HFpEF. This HF phenotype is often associated with extensive comorbid pathology (arterial hypertension, type 2 diabetes mellitus, atrial fibrillation, obesity, etc.). Until now, the features of the clinical portrait of a patient with hypertension complicated by HFpEF, occurring without known concomitant diseases and conditions, have not been sufficiently covered.
Full Text
##article.viewOnOriginalSite##About the authors
A. V. Barsukov
KardioKlinika; S.M. Kirov Military Medical Academy, Ministry of Defense of Russia
Author for correspondence.
Email: avbarsukov@yandex.ru
ORCID iD: 0000-0002-1943-9545
SPIN-code: 1516-0095
Professor, MD
Russian Federation, Saint PetersburgA. V. Airapetyan
KardioKlinika; I.I. Mechnikov North-West State Medical University, Ministry of Health of Russia
Email: avbarsukov@yandex.ru
Russian Federation, Saint Petersburg
S. A. Glebova
KardioKlinika
Email: avbarsukov@yandex.ru
ORCID iD: 0000-0003-1627-587X
SPIN-code: 9431-4642
Candidate of Medical Sciences
Russian Federation, Saint PetersburgG. B. Saraev
Saint Petersburg Institute of Bioregulation and Gerontology
Email: avbarsukov@yandex.ru
ORCID iD: 0000-0002-5349-7781
SPIN-code: 8233-0564
Russian Federation, Saint Petersburg
E. V. Borisova
KardioKlinika; I.I. Mechnikov North-West State Medical University, Ministry of Health of Russia
Email: avbarsukov@yandex.ru
ORCID iD: 0000-0002-0960-9627
SPIN-code: 1694-8120
Associate Professor, MD
Russian Federation, Saint PetersburgReferences
- Borlaug B.A., Sharma K., Shah S.J. et al. Heart failure with preserved ejection fraction. J Am Coll Cardiol. 2023; 81: 1810–34. doi: 10.1016/j.jacc.2023.01.049
- Галявич А.С., Терещенко С.Н., Ускач Т.М. и др. Хроническая сердечная недостаточность. Клинические рекомендации 2024. Российский кардиологический журнал. 2024; 29 (11): 6162 [Galyavich A.S., Tereshchenko S.N., Uskach T.M. et al. 2024 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2024; 29 (11): 6162 (in Russ.)]. doi: 10.15829/1560-4071-2024-6162
- Bozkurt B., Ahmad T., Alexander K.M. et al. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America. J Card Fail. 2023; 29 (10): 1412–51. doi: 10.1016/j.cardfail.2023.07.006
- Ситникова М.Ю, Лясникова Е.А., Юрченко А.В. и др. Результаты 3-х летней работы Российского госпитального регистра хронической сердечной недостаточности (RUssian hoSpital Heart Failure Registry – RUS-HFR): взаимосвязь менеджмента и исходов у больных хронической сердечной недостаточностью. Кардиология. 2018; 58 (S10): 9–19 [Sitnikova M.Yu., Lyasnikova E.A., Yurchenko A.V. et al. Results of 3 years work of the Russian hospital register of chronic heart failure (RUssian hoSpital Heart Failure Registry -RUS-HFR): relationship between management and outcomes in patients with chronic heart failure. Kardiologiia. 2018; 58 (10S): 9–19 (in Russ.)]. doi: 10.18087/cardio.2483
- Shahim B., Kapelios C.J., Savarese G. et al. Global Public Health Burden of Heart Failure: An Updated Review. Card Fail Rev. 2023; 9: e11. doi: 10.15420/cfr.2023.05
- Dhingra A., Garg A., Kaur S. et al. Epidemiology of heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2014; 11 (4): 354–65. doi: 10.1007/s11897-014-0223-7
- Liu M., Fang F., Yu C.M. Noncardiac comorbidities in heart failure with preserved ejection fraction – commonly ignored fact. Circ J. 2015; 79 (5): 954–9. doi: 10.1253/circj.CJ-15-0056
- Dunlay S.M., Roger V.L., Redfield M.M. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017; 14 (10): 591–602. doi: 10.1038/nrcardio.2017.65
- Ketchum E.S., Levy W.C. Establishing prognosis in heart failure: a multimarker approach. Prog Cardiovasc Dis. 2011; 54 (2): 86–96. doi: 10.1016/j.pcad.2011.03.003
- Ho K.K., Anderson K.M., Kannel W.B. et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993; 88 (1): 107–15. doi: 10.1161/01.cir.88.1.107
- Reddy Y.N.V., Carter R.E., Obokata M. et al. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018; 138: 861–70. doi: 10.1161/CIRCULATIONAHA.118.034646
- Pieske B., Tschöpe C., de Boer R.A. et al. How to diagnose heart failure with preserved ejection fraction: the HFAPEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019; 40 (40): 3297–317. doi: 10.1093/eurheartj/ehz641
- Агеев Ф.Т., Яровая Е.Б., Овчинников А.Г. К вопросу о возможности использования европейского (HFA–PEFF) и американского (Н2FPEF) алгоритмов диагностики сердечной недостаточности с сохраненной фракцией выброса левого желудочка в условиях реальной российской клинической практики. Кардиология. 2022; 62 (12): 4–10 [Ageev F.T., Yarovaya E.B., Ovchinnikov A.G. Рossibility of using European (HFA-PEFF) and American (H2FPEF) algorithms for diagnosing heart failure with preserved ejection fraction in Russian clinical practice. Kardiologiia. 2022; 62 (12): 4–10 (in Russ.)]. doi: 10.18087/cardio.2022.12.n2280
- Овчинников А.Г., Агеев Ф.Т., Алехин М.Н. и др. Диастолическая трансторакальная стресс-эхокардиография с дозированной физической нагрузкой в диагностике сердечной недостаточности с сохраненной фракцией выброса: показания, методология, интерпретация результатов. Согласованное мнение экспертов, выработанное под эгидой ФГБУ "Национальный медицинский исследовательский центр кардиологии" МЗ РФ, Общества специалистов по сердечной недостаточности (ОССН) и Российской ассоциации специалистов ультразвуковой диагностики в медицине (РАСУДМ). Кардиология. 2020; 60 (12): 48–63 [Ovchinnikov A.G., Ageev F.T., Alekhin M.N. et al. The role of diastolic transthoracic stress echocardiography with incremental workload in the evaluation of heart failure with preserved ejection fraction: indications, methodology, interpretation. Expert consensus developed under the auspices of the National Medical Research Center of Cardiology, Society of Experts in Heart Failure (SEHF), and Russian Association of Experts in Ultrasound Diagnosis in Medicine (REUDM). Kardiologiia. 2020; 60 (12): 48–63 (in Russ.)]. doi: 10.18087/cardio.2020.12.n1219
- Erdei T., Smiseth O.A., Marino P. et al. A systematic review of diastolic stress tests in heart failure with preserved ejection fraction, with proposals from the EU-FP7 MEDIA study group. Eur J Heart Fail. 2014; 16 (12): 1345–61. doi: 10.1002/ejhf.184
- Donal E., Lund L.H., Oger E. et al.; KaRen investigators. Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study. Eur Heart J Cardiovasc Imaging. 2016; 17 (1): 106–13. doi: 10.1093/ehjci/jev144
- Борисова Е.В., Барсуков А.В., Глебова С.А. и др. Влияние ингибиторов натрий-глюкозного котранспортера 2-го типа на диастолическую функцию левого желудочка: текущее состояние вопроса и перспективы. Кардиология. 2024; 64 (7): 64–71 [Borisova E.V., Barsukov A.V., Glebova S.A. et al. The effect of sodium-glucose cotransporter type 2 inhibitors on left ventricular diastolic function: current status and prospects. Kardiologiia. 2024; 64 (7): 64–71 (in Russ.)]. doi: 10.18087/cardio.2024.7.n2545
- Дедов Д. Лечение возможных кардиоваскулярных осложнений при ИБС и ХСН. Врач. 2011; 9: 66–8 [Dedov D. Treatment of possible cardiovascular complications in ischemic heart disease and chronic heart failure. Vrach. 2011; 9: 66–8 (in Russ.)].
- Lang R.M., Badano L.P., Mor-Avi V. et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28 (1): 1–39.e14. doi: 10.1016/j.echo.2014.10.003
- Nagueh S.F., Smiseth O.A., Appleton C.P. et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016; 29 (4): 277–314. doi: 10.1016/j.echo.2016.01.011
- Борисова Е.В., Барсуков А.В., Глебова С.А. и др. Динамика показателей диастолы левого желудочка у пациентов с гипертонической болезнью, осложненной сердечной недостаточностью с сохраненной фракцией выброса, на фоне 12-недельной терапии, содержащей ингибитор натрий-глюкозного котранспортера 2-го типа. Лечение и профилактика. 2024; 14 (4): 21–33 [Borisova E.V., Barsukov A.V., Glebova S.A. et al. Dynamics of left ventricular diastolic parameters in patients with hypertension complicated by heart failure with preserved ejection fraction during 12 weeks of therapy with a sodium-glucose cotransporter 2 inhibitor. Treatment and Prevention. 2024; 14 (4): 21–33 (in Russ.)].
Supplementary files
